| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 04/16/2008 | CN101161635A Industrial method for producing natural capsicine |
| 04/16/2008 | CN100381418C Gelling agents |
| 04/15/2008 | US7358396 can be resolved using optically active carboxylic acids or enzymes; compounds such as 1-benzyloxy-3-aminobutane |
| 04/15/2008 | US7358394 Process for preparing N,N′-dialkoxy-N, N′-dialkyl oxamide |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358073 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4- pyrimidinyl)-amino-2-cyclopentenyl-1-methanol |
| 04/15/2008 | CA2337452C Process for the preparation of 4,5-diamino shikimic acid derivatives |
| 04/15/2008 | CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols |
| 04/10/2008 | WO2008041571A1 Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester |
| 04/10/2008 | WO2008040560A1 Process for the preparation of memantine and its hydrochloric acid salt form |
| 04/10/2008 | WO2008008701B1 Substituted cyclopentane derivatives as therapeutic agents |
| 04/10/2008 | US20080086016 lisdexamfetamine, lisdexamfetamine dimesylate and lisdexamfetamine hydrochloride; attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity |
| 04/10/2008 | US20080085994 T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 04/10/2008 | US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | DE102006047619A1 Verfahren zur Herstellung basischer Fettsäureamide A process for the preparation of basic fatty acid amides |
| 04/10/2008 | DE102006047617A1 Verfahren zur Herstellung basischer (Meth)acrylamide A process for the preparation of basic (meth) acrylamides |
| 04/09/2008 | EP1908748A1 Process for the preparation of memantine and its hydrochloric acid salt form |
| 04/09/2008 | EP1907358A2 Bicyclic derivatives as p38 kinase inhibitors |
| 04/09/2008 | EP1907353A2 Bis-aromatic amides and their uses as sweet flavor modifiers, tastants and taste enhancers |
| 04/09/2008 | EP1299348B1 Compounds and compositions for delivering active agents |
| 04/09/2008 | CN101160282A Acetylene derivatives |
| 04/09/2008 | CN101157627A New method for synthesizing nateglinide |
| 04/09/2008 | CN101157626A Method for purifying N,N-dimethyl formamide |
| 04/09/2008 | CN101157590A Method for preparing alpha-aryl carbonyl compound |
| 04/09/2008 | CN101156840A Inhibitors of oleamide hydrolase |
| 04/09/2008 | CN100379729C Nitro compounds and their application in preparation of pemetrexed |
| 04/08/2008 | US7355079 Thyronamine derivatives and analogs and methods of use thereof |
| 04/08/2008 | US7355074 Especially calix[4]arene amides, e.g., calix[4]arene tetrabutylamide-1,3-alt; capable of forming a chloride ion channel across a lipid bilayer, and transporting chloride ion across the bilayer |
| 04/07/2008 | CA2579596A1 Preparation of oseltamivir phosphate (tamiflu(r)) and intermediates starting from d-glucose or d-xylose |
| 04/03/2008 | WO2008039522A1 Cooling confectioneries and beverages |
| 04/03/2008 | US20080081928 reacting 2-chloro-5-iodo-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide with allyl alcohol in the presence of a palladium catalyst and a tertiary amine base, to form 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; chemical intermediates for drugs |
| 04/03/2008 | US20080081927 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |
| 04/03/2008 | US20080081909 Process for producing olefins |
| 04/03/2008 | US20080081851 Optical polymers with higher refractive index |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080081789 Beta peptoids with antimicrobial activity |
| 04/03/2008 | CA2661581A1 Cooling confectioneries and beverages |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1904439A2 Sphingosine kinase inhibitors |
| 04/02/2008 | EP1904436A1 Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |
| 04/02/2008 | EP1765771A4 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 04/02/2008 | CN101155776A Process for producing tricarboxylic acid tris(alkyl-substituted cyclohexylamide) |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/02/2008 | CN100378056C Luminous compounds and labeling reagents using the same |
| 04/01/2008 | US7351862 Alpha, omega-difunctional aldaramides |
| 04/01/2008 | US7351861 Halo-substituted N-arylanilides with one or more hydroxy groups that may be esterified; N-benzilideneiminoarylamides; antibacterial agents |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351716 Dermatological preparations |
| 03/27/2008 | WO2008035380A2 An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts |
| 03/27/2008 | US20080076941 Optically active bisoxazoline compounds, process for production of the same and use thereof |
| 03/27/2008 | US20080076931 Optically active bisoxazoline compounds, process for production of the same and use thereof |
| 03/27/2008 | US20080076887 Process for production of molecular devices |
| 03/27/2008 | US20080076869 Three-dimensional molecular devices of highly dense molecules; Nanowire |
| 03/27/2008 | US20080076828 Substituted acylanilides and methods of use thereof |
| 03/27/2008 | US20080076807 Treating diseases related to TNF or cytokine overproduction; antitumor agents; autoimmune diseases, neurodegenerative diseases; hydroxamic acid derivatives containing an alpha-aminoacyl moiety such as 4-(2(R)-Benzoylamino-3-naphthalen-2-yl-propionylamino)-N-hydroxy-benzamide |
| 03/27/2008 | US20080076806 Glycine transporter gene 1 (GlyT-1); psychosis, schizophrenia, dementia; activation of NMDA receptors via GlyT-1 inhibition; N-(([(4-chloro-phenyl)-phenyl-methyl]-carbamoyl)-methyl)-4-fluorobenzamide for example |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/26/2008 | EP1819662B1 Method for purifying polar vinyl compounds |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | CN100376545C Process for preparing N,N-dimethyl chloroacetamide |
| 03/25/2008 | USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 03/25/2008 | US7348457 N-[9-hydroxy-10-oxo-12(Z),15(Z)-eicosadienoyl]-L-isoleucine; for providing flower bud promoting activity, stress-resistance, antiaging activity to the plants |
| 03/25/2008 | US7348456 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents |
| 03/25/2008 | US7348449 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 03/25/2008 | US7348448 Substituted phenyl esters; dementia |
| 03/25/2008 | US7348437 Compound with a hydroxamate and a benzophenone group, and a functional group of rhodamine, oligonucleotides, azides, alkynes, biotin, or p-nitrophenyl; binding the active compound to the active site, forming an active compound-metalloprotease adduct; determining the potency of the inhibitor |
| 03/25/2008 | US7348353 Acetylene derivatives having mGluR 5 antagonistic activity |
| 03/25/2008 | US7348173 Fatty-acid amide hydrolase |
| 03/20/2008 | WO2008031811A1 Nitrate esters of aminoalcohols |
| 03/20/2008 | WO2008031534A1 Insecticidal compounds |
| 03/20/2008 | WO2008031157A1 Acetylenic compounds |
| 03/20/2008 | WO2008015133A3 Process for preparing amidrazones |
| 03/20/2008 | WO2007120379A3 Sulfonanilide analogs as selective aromatase modulators |
| 03/20/2008 | US20080070989 Method of Evaluating Evenness of Suplatast Tosilate Crystal, Even Crystal, and Process for Producing the Same |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070887 Diaryl Ether Derivatives and Uses Thereof |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080067123 carbon surfaces such as carbon black, fullerenes, graphite, and activated carbon are modified by reacting with a reactant having at least one double bond and one or more electron withdrawing groups, e.g. maleic anhydride; reactive carbon surface can be further functionalized by nucleophilic groups |
| 03/20/2008 | CA2663132A1 Acetylenic compounds |
| 03/20/2008 | CA2663129A1 Nitrate esters of aminoalcohols |
| 03/19/2008 | EP1900759A2 Polymer production |
| 03/19/2008 | EP1900740A1 Process for producing tricyclic ketone |
| 03/19/2008 | EP1900723A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 03/19/2008 | EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/19/2008 | EP1898899A1 Inhibitors of fibroblast activation protein alpha |
| 03/19/2008 | CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 03/19/2008 | CN101146764A Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 03/19/2008 | CN101146760A Intermediate in production of [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound |
| 03/19/2008 | CN101143833A Fluorine-containing rosin amide and its preparation method and use |
| 03/19/2008 | CN101143832A Method for preparing N,N-dialkylacrylamide |
| 03/19/2008 | CN101143831A Method for preparing acrylamide crystal |
| 03/18/2008 | US7345200 Phase change ink formulations, colorant formulations, and methods of forming colorants |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7344868 Amide formation and esterification performed by lipases, between fatty acids and/or esters of fatty acids and amino-alcohols; used in the form of cosmetic and/or dermatology |
| 03/18/2008 | CA2256379C Substance mixtures comprising vinyl-containing compounds and stabilizers |